DK3283064T3 - Derivater til anvendelse i behandling af muskelatrofi - Google Patents
Derivater til anvendelse i behandling af muskelatrofiInfo
- Publication number
- DK3283064T3 DK3283064T3 DK16729310.9T DK16729310T DK3283064T3 DK 3283064 T3 DK3283064 T3 DK 3283064T3 DK 16729310 T DK16729310 T DK 16729310T DK 3283064 T3 DK3283064 T3 DK 3283064T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- treatment
- muscle atrophy
- atrophy
- muscle
- Prior art date
Links
- 206010028289 Muscle atrophy Diseases 0.000 title 1
- 230000020763 muscle atrophy Effects 0.000 title 1
- 201000000585 muscular atrophy Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1553410A FR3035105A1 (fr) | 2015-04-16 | 2015-04-16 | Derives utiles dans le traitement de l'atrophie musculaire |
| PCT/FR2016/050864 WO2016166480A1 (fr) | 2015-04-16 | 2016-04-14 | Dérives utiles dans le traitement de l'atrophie musculaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3283064T3 true DK3283064T3 (da) | 2019-08-12 |
Family
ID=53758355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16729310.9T DK3283064T3 (da) | 2015-04-16 | 2016-04-14 | Derivater til anvendelse i behandling af muskelatrofi |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10350184B2 (da) |
| EP (1) | EP3283064B1 (da) |
| JP (1) | JP6669774B2 (da) |
| KR (1) | KR20170137201A (da) |
| CN (1) | CN107735082B (da) |
| CA (1) | CA2988625A1 (da) |
| DK (1) | DK3283064T3 (da) |
| ES (1) | ES2741012T3 (da) |
| FR (1) | FR3035105A1 (da) |
| PL (1) | PL3283064T3 (da) |
| PT (1) | PT3283064T (da) |
| RU (1) | RU2715553C2 (da) |
| WO (1) | WO2016166480A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3055548B1 (fr) * | 2016-09-05 | 2018-09-28 | Metabrain Research | Utilisation de metabolites du tryptophane dans le traitement de l'atrophie musculaire |
| FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
| CN111253246B (zh) * | 2020-03-16 | 2023-03-17 | 中国医学科学院基础医学研究所 | 酰基酸类衍生物及其制备方法和医药用途 |
| CN114533731B (zh) * | 2022-02-25 | 2024-06-04 | 上海大学 | 一种氨基吡啶衍生物在制备肌肉萎缩抑制剂中的应用 |
| CN117205215B (zh) * | 2023-11-08 | 2024-01-26 | 广州喜鹊医药有限公司 | 川芎嗪硝酮衍生物在制备预防或治疗肌少症药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2204406A1 (en) * | 1972-10-26 | 1974-05-24 | Delalande Sa | 1-Phenyl-3-aminocarbonylpropan-1-one oxime carbamates - with analgesic, antiinflammatory, hypotensive and sedative activities etc. |
| WO1998009940A1 (en) * | 1996-09-04 | 1998-03-12 | Warner-Lambert Company | Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| US6541521B1 (en) * | 1999-07-12 | 2003-04-01 | Warner-Lambert Company | Benzene butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| ATE265998T1 (de) * | 2000-03-20 | 2004-05-15 | N Gene Res Lab Inc | Propancarbonsäure-amidoxim derivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese entahlten |
| ES2439736T3 (es) * | 2005-11-08 | 2014-01-24 | Vertex Pharmaceuticals Incorporated | Moduladores heterocíclicos de transportadores de casete de unión a ATP |
| WO2010011302A1 (en) * | 2008-07-22 | 2010-01-28 | Chdi, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2017044551A1 (en) * | 2015-09-11 | 2017-03-16 | Mitobridge, Inc. | Ppar-alpha agonists for treating mitochondrial diseases |
-
2015
- 2015-04-16 FR FR1553410A patent/FR3035105A1/fr active Pending
-
2016
- 2016-04-14 KR KR1020177033178A patent/KR20170137201A/ko active IP Right Grant
- 2016-04-14 EP EP16729310.9A patent/EP3283064B1/fr active Active
- 2016-04-14 JP JP2017554365A patent/JP6669774B2/ja active Active
- 2016-04-14 DK DK16729310.9T patent/DK3283064T3/da active
- 2016-04-14 PL PL16729310T patent/PL3283064T3/pl unknown
- 2016-04-14 ES ES16729310T patent/ES2741012T3/es active Active
- 2016-04-14 PT PT16729310T patent/PT3283064T/pt unknown
- 2016-04-14 CN CN201680034525.4A patent/CN107735082B/zh active Active
- 2016-04-14 WO PCT/FR2016/050864 patent/WO2016166480A1/fr active Application Filing
- 2016-04-14 RU RU2017139915A patent/RU2715553C2/ru active
- 2016-04-14 CA CA2988625A patent/CA2988625A1/en active Pending
- 2016-04-14 US US15/566,955 patent/US10350184B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017139915A3 (da) | 2019-06-06 |
| CN107735082A (zh) | 2018-02-23 |
| JP2018513162A (ja) | 2018-05-24 |
| EP3283064A1 (fr) | 2018-02-21 |
| CA2988625A1 (en) | 2016-10-20 |
| PT3283064T (pt) | 2019-08-21 |
| CN107735082B (zh) | 2021-07-27 |
| RU2715553C2 (ru) | 2020-03-02 |
| JP6669774B2 (ja) | 2020-03-25 |
| WO2016166480A1 (fr) | 2016-10-20 |
| US20180303780A1 (en) | 2018-10-25 |
| KR20170137201A (ko) | 2017-12-12 |
| PL3283064T3 (pl) | 2019-12-31 |
| ES2741012T3 (es) | 2020-02-07 |
| EP3283064B1 (fr) | 2019-05-08 |
| FR3035105A1 (fr) | 2016-10-21 |
| US10350184B2 (en) | 2019-07-16 |
| RU2017139915A (ru) | 2019-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3143025T3 (da) | Forbindelser til behandling af spinal muskelatrofi | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3317286T3 (da) | Cykliserede sulfamoylarylamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3490582T3 (da) | Sammensætninger til anvendelse i behandling af myelofibrose | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| BR112016025246A2 (pt) | composição de preservativo de madeira | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3265087T3 (da) | Fremgangsmåde til behandling med tradipitant | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| DK3297653T3 (da) | Behandling af postbariatrisk hypoglykæmi med glp-1-antagonister | |
| DK3310190T3 (da) | Sammensætning til behandling af kød og anvendelse af denne | |
| DK3110446T3 (da) | Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme | |
| DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
| DK3506901T3 (da) | Anvendelse af kynurensyre til behandling af muskelatrofi | |
| DK3283064T3 (da) | Derivater til anvendelse i behandling af muskelatrofi | |
| DK3442558T3 (da) | Bmp-7-afledte peptider til anvendelse i behandlingen af osteoartritis | |
| DK3169405T3 (da) | Fremgangsmåder, forbindelser og sammensætninger til behandling af muskel- og skeletsygdomme |